Work

Non-Coding RNAs as Theranostics in Human Cancers

Year: 2014

Type: article

Abstract: In Redis et al. the funding information as shown in the Acknowledgments was incomplete. The corrected section is shown below G.A.C. is supported as a Fellow at The University of Texas MD AndersonResearch Trust, as a University of Texas System Regents Research Scholar and by the CLL Global Research Foundation. Work in Dr. Calin's laboratory is supported in part by the NIH/NCI (CA135444), a Department of Defense Breast Cancer Idea Award, Developmental Research Awards in Breast Cancer, Ovarian Cancer, Brain Cancer, Multiple Myeloma and Leukemia SPOREs, a 2009 Seena Magowitz–Pancreatic Cancer Action Network AACR Pilot Grant, and the Laura and John Arnold Foundation and RGK Foundation. Dr. Berindan-Neagoe was financed by a POSCCE grant (709/2010) entitled Clinical and Economical Impact of Proteome and Transcriptome Molecular Profiling in Neoadjuvant Therapy of Triple Negative Breast Cancer (BREASTIMPACT). Redis, RS, Berindan-Neagoe, I, Pop, VI, Calin, GA. 2012. Non-coding RNAs as theranostics in human cancers. J Cell Biochem 113: 1451– 1459. doi: 10.1002/jcb.24038.

Source: Journal of Cellular Biochemistry

DOI: 10.1002/jcb.24758

Authors: R. S. Redis, I. Berindan-Neagoe, V. I. Pop, G. A. Calin

Institutions: The University of Texas MD Anderson Cancer Center, Iuliu Hațieganu University of Medicine and Pharmacy, Institute of Oncology Prof. Dr. Ion Chiricuta

Language: English

Topic: Cancer-related molecular mechanisms research

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze